These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Speech blockage induced by maprotiline. Sandyk R Am J Psychiatry; 1986 Mar; 143(3):391-2. PubMed ID: 3953878 [No Abstract] [Full Text] [Related]
11. [Maprotiline and its undesired effects]. Tesarová O Act Nerv Super (Praha); 1982 May; 24(2):90-2. PubMed ID: 7048836 [No Abstract] [Full Text] [Related]
12. Seizures and maprotiline. Bick P J Clin Psychiatry; 1982 Oct; 43(10):434. PubMed ID: 7118841 [No Abstract] [Full Text] [Related]
13. Case report of hepatotoxicity associated with maprotiline. Weinstein RP; Gosselin JY Can J Psychiatry; 1988 Apr; 33(3):233-4. PubMed ID: 3383098 [TBL] [Abstract][Full Text] [Related]
14. Seizures associated with high maprotiline serum concentrations. Molnar G Can J Psychiatry; 1983 Nov; 28(7):555-6. PubMed ID: 6418369 [TBL] [Abstract][Full Text] [Related]
15. Maprotiline hydrochloride and convulsions: a case report. Schwartz L; Swaminathan S Am J Psychiatry; 1982 Feb; 139(2):244-5. PubMed ID: 6798885 [No Abstract] [Full Text] [Related]
16. Cutaneous vasculitis from maprotiline. Oakley AM; Hodge L Aust N Z J Med; 1985 Apr; 15(2):256-7. PubMed ID: 3161496 [TBL] [Abstract][Full Text] [Related]